CH397698A - Process for the production of new 1-carbamyl-indazoles - Google Patents
Process for the production of new 1-carbamyl-indazolesInfo
- Publication number
- CH397698A CH397698A CH1042561A CH1042561A CH397698A CH 397698 A CH397698 A CH 397698A CH 1042561 A CH1042561 A CH 1042561A CH 1042561 A CH1042561 A CH 1042561A CH 397698 A CH397698 A CH 397698A
- Authority
- CH
- Switzerland
- Prior art keywords
- carbamyl
- indazoles
- chloro
- reacted
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung neuer 1"Carbamylindazole
Es wurde gefunden, dass man zu pharmazeutisch wertvollen Carbamyl-indazolen der allgemeinen For mrl
EMI1.1
kommt, in der R ein Halogenatom bedeutet, wenn R' Wasserstoff ist, und umgekehrt, wenn man die entsprechenden halogensubstituierten Indazole entweder mit Carbamylchlorid oder mit Phosgen umsetzt und im letzteren Falle das Zwischenprodukt mit Ammoniak zur Reaktion bringt.
Unter den neuen Indazolen hat sich insbesondere das 3-Chlor-l-carbamyl-indazol pharmakologisch als wertvoll erwiesen. Es zeigt eine entspannende Wirkung und ruft eine Dämpfung der Schmerzempfindung hervor. In mancher Hinsicht weist es eine Shn- lichkeit mit den Barbituraten auf, ohne jedoch deren schlafinduzierende Wirkung zu zeigen. Darüberhinaus wirken diese Verbindungen, insbesondere die zuletzt genannte, auch antiphlogistisch und analgetisch.
Beispiele
1. 12 g 3-Chlor-indazol werden in 200 cm3 Toluol suspendiert. Bei einer Temperatur zwischen -10 und +250 leitet man Phosgen ein, bis die berechnete Menge davon aufgenommen worden ist. Man destilliert vom Lösungsmittel ab und erhält das entsprechende Chlorkohlensäurederivat (Smp. 90-95 ). 12 g dieser Verbindung werden im Anschluss daran in 340/oigem wässerigem Ammoniak suspendiert und unter Rühren auf etwa 450 erwärmt. Man destilliert das Wasser ab und erhält das 3-Chlor-1-carbamyl- indazol, welches nach dem Umkristallisieren aus 960/oigem Alkohol zwischen 172 und 1740 schmilzt.
Berechnet: Cd 18,16
Gefunden: C1 18,30.
2. Arbeitet man wie oben, ersetzt aber das 3 Chlorindazol durch das 6-Chlorindazol, so erhält man das 6-Chlor-1-carbamyl-indazol, das aus Dioxan umkristallisiert bei 223-226 schmilzt.
Berechnet: C1 18,15
Gefunden: C1 18,20.
PATENTANSPRUCH
Verfahren zur Herstellung von neuen l-Carbamyl-indazolen der Formel
EMI1.2
in der R ein Halogenatom bedeutet, wenn R' Wasserstoff ist, und umgekehrt, dadurch gekennzeichnet, dass man die entsprechenden halogensubstituierten Indazole entweder mit Carbamylchlorid oder mit Phosgen umsetzt und im letzteren Fall das Zwischenprodukt mit Ammoniak zur Reaktion bringt.
**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.
Process for the preparation of new 1 "carbamylindazoles
It has been found that pharmaceutically useful carbamyl indazoles of the general formula mrl
EMI1.1
comes, in which R denotes a halogen atom when R 'is hydrogen, and vice versa, if the corresponding halogen-substituted indazoles are reacted either with carbamyl chloride or with phosgene and in the latter case the intermediate is reacted with ammonia.
Among the new indazoles, 3-chloro-1-carbamyl-indazole in particular has proven to be pharmacologically valuable. It has a relaxing effect and dampens the sensation of pain. In some respects it is similar to barbiturates, but without showing their sleep-inducing effect. In addition, these compounds, especially the last-mentioned, also have an anti-inflammatory and analgesic effect.
Examples
1. 12 g of 3-chloro-indazole are suspended in 200 cm3 of toluene. Phosgene is introduced at a temperature between -10 and +250 until the calculated amount has been absorbed. The solvent is distilled off and the corresponding chlorocarbonic acid derivative (melting point 90-95) is obtained. 12 g of this compound are then suspended in 340% aqueous ammonia and heated to about 450 with stirring. The water is distilled off and the 3-chloro-1-carbamylindazole is obtained, which melts between 172 and 1740 after recrystallization from 960% alcohol.
Calculated: Cd 18.16
Found: C1 18.30.
2. If you work as above, but replace the 3-chloroindazole with the 6-chloroindazole, you get 6-chloro-1-carbamyl-indazole, which, recrystallized from dioxane, melts at 223-226.
Calculated: C1 18.15
Found: C1 18.20.
PATENT CLAIM
Process for the preparation of new l-carbamyl-indazoles of the formula
EMI1.2
in which R denotes a halogen atom when R 'is hydrogen, and vice versa, characterized in that the corresponding halogen-substituted indazoles are reacted either with carbamyl chloride or with phosgene and in the latter case the intermediate is reacted with ammonia.
** WARNING ** End of DESC field could overlap beginning of CLMS **.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1042561A CH397698A (en) | 1961-09-08 | 1961-09-08 | Process for the production of new 1-carbamyl-indazoles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1042561A CH397698A (en) | 1961-09-08 | 1961-09-08 | Process for the production of new 1-carbamyl-indazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
CH397698A true CH397698A (en) | 1965-08-31 |
Family
ID=4363088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1042561A CH397698A (en) | 1961-09-08 | 1961-09-08 | Process for the production of new 1-carbamyl-indazoles |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH397698A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4051252A (en) * | 1974-12-13 | 1977-09-27 | Bayer Aktiengesellschaft | 3-aminoindazole-1 and 2-carboxylic acid derivatives |
-
1961
- 1961-09-08 CH CH1042561A patent/CH397698A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4051252A (en) * | 1974-12-13 | 1977-09-27 | Bayer Aktiengesellschaft | 3-aminoindazole-1 and 2-carboxylic acid derivatives |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1223394B (en) | Process for the preparation of 5-acylaminopyrazole derivatives and their salts | |
CH397698A (en) | Process for the production of new 1-carbamyl-indazoles | |
DE2121694C3 (en) | ||
CH366523A (en) | Process for the production of the new 1,3,4,6- and 1,3,4,5-tetranicotinoyl-fructose | |
DE3005359C2 (en) | N-m-trifluoromethylphenyl anthranilates of o-alkoxycarbonylphenols, processes for their preparation and pharmaceuticals containing these compounds | |
DE2403786A1 (en) | NEW DERIVATIVES OF CUMARINE | |
DE2053205A1 (en) | Dihydrofurandenvate and process for their preparation | |
AT211317B (en) | Process for the preparation of the new 4- [β- (3,4-dimethoxyphenyl) ethyl] -2,6-diketopiperazine | |
AT229866B (en) | Process for the preparation of the new 1,2-diphenyl-4-carbamoyl-3, 5-pyrazolidinedione | |
DE2658840A1 (en) | PHARMACEUTICAL COMPOSITION | |
AT227707B (en) | Process for the production of new quinazolinone derivatives | |
AT249650B (en) | Process for the preparation of the dimethylaminoethyl monoester of succinic acid in the form of its inner salt | |
AT288398B (en) | Process for the preparation of new cinnamic acid amides | |
AT217048B (en) | Process for the preparation of new theophylline derivatives substituted in the 7-position | |
AT231462B (en) | Process for the production of new guanylhydrazones | |
AT226710B (en) | Process for the preparation of new dihydroquinoxalones (2) and their salts | |
AT257058B (en) | Process for the preparation of the new bis-pyridylmethyl disulfide | |
DE951004C (en) | Process for the preparation of hydrazones of cyanoacetic acid hydrazide with ketocarboxylic acids or their esters | |
AT211302B (en) | Process for the preparation of new monoalkylaminopropionyl toluidides and their salts | |
AT242868B (en) | Process for the preparation of new 18-azido-18-deoxy-reserp acid esters and their salts | |
AT241708B (en) | Process for the preparation of new derivatives of 3-keto steroids | |
AT230372B (en) | Process for the preparation of new 4-amino-1-phenyl-2,3-dimethyl-pyrazolone derivatives | |
DE2833073A1 (en) | THIOURA DERIVATIVES, PROCESS FOR THEIR MANUFACTURING, USE OF THE SAME AND MEDICINAL PRODUCTS CONTAINING THEM | |
AT223188B (en) | Process for the preparation of new N, N-disubstituted monoaminoalkylamides and their salts | |
AT241452B (en) | Process for the preparation of new 2-acyl derivatives of 5-amino-isoindoline |